ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 123111 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 123111; 2) Community: the network communities that were significantly associated with the response to NSC 123111; 3) Molecule: the relationships between components within communities and NSC 123111; 4) MDR: the compounds that were significantly associated with the NSC 123111.

NSC Compound Enrichment Correlation
NSC 300289 Pinafide 0.0105244982742821 0.51589921
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0105244982742821 0.45351271
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0105244982742821 0.4337167
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0105244982742821 0.2532395
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0105244982742821 0.49760831
NSC 629229 Null 0.0105244982742821 0.087912803
NSC 63878 Cytarabine Hydrochloride AZ 0.0105244982742821 0.51294934
NSC 67091 Null 0.0105244982742821 0.24987975
NSC 673652 2-Ethylaminoestradiol 0.0105244982742821 0.10347403
NSC 683556 Camptothecin Derivative 0.0105244982742821 0.55119462
Total:79  Current:27    [First] [Prev] [Next] [Last]